rs1330950
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs1330950(A;A) |
Make rs1330950(A;C) |
Make rs1330950(C;C) |
Reference | GRCh38 38.1/142 |
Chromosome | 13 |
Position | 106686453 |
is a | snp |
is | mentioned by |
dbSNP | rs1330950 |
dbSNP (classic) | rs1330950 |
ClinGen | rs1330950 |
ebi | rs1330950 |
HLI | rs1330950 |
Exac | rs1330950 |
Gnomad | rs1330950 |
Varsome | rs1330950 |
LitVar | rs1330950 |
Map | rs1330950 |
PheGenI | rs1330950 |
Biobank | rs1330950 |
1000 genomes | rs1330950 |
hgdp | rs1330950 |
ensembl | rs1330950 |
geneview | rs1330950 |
scholar | rs1330950 |
rs1330950 | |
pharmgkb | rs1330950 |
gwascentral | rs1330950 |
openSNP | rs1330950 |
23andMe | rs1330950 |
SNPshot | rs1330950 |
SNPdbe | rs1330950 |
MSV3d | rs1330950 |
GWAS Ctlg | rs1330950 |
Max Magnitude | 0 |
? | (A;A) (A;C) (C;C) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 24554482] |
Trait | Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy) |
Title | Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384. |
Risk Allele | |
P-val | 8E-7 |
Odds Ratio | 17.50 [NR] |